|Support for this
program provided by:
Thank you for participating in the program. Your responses on this evaluation help us improve future programs. Please scroll down to complete the evaluation and submit your responses by clicking on the red button at the bottom of the page. Required questions are indicated with an asterick (*).
|Strongly Disagree||Disagree||Agree||Strongly Agree|
|Current treatment options for patients living with ALL|
|The impact of minimal residual disease (MRD)|
|Clinical trials and emerging therapies for ALL treatment|
|The importance of open communication with your healthcare team to promote a better quality of life|
If you have additional questions following this program, please contact an Information Specialist for accurate, up-to-date disease and treatment information, and for support with treatment and financial challenges you may be facing. (800) 955-4572 or infocenter@LLS.org.
|Instructions for Navigation: